Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
about
Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritisIL-17RC: a partner in IL-17 signaling and beyondT helper 17 cells promote cytotoxic T cell activation in tumor immunityTumor-specific Th17-polarized cells eradicate large established melanomaEntirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune ResponsesFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsThe role and regulation of human Th17 cells in tumor immunityTh17 Cell Plasticity and Functions in Cancer ImmunityNrf2 Induces IL-17D to Mediate Tumor and Virus SurveillanceAntagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesisPrognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas.Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma modelIL-17A (-197G/A) and IL-17F (7488T/C) gene polymorphisms and cancer risk in Asian population: a meta-analysis.Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients.Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in miceIL-17 contributes to angiogenesis in rheumatoid arthritis.The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma.Interleukin-17 regulation: an attractive therapeutic approach for asthmaPotential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinomaTh17 cells are involved in the local control of tumor progression in primary intraocular lymphoma.Up-regulation of Th17 cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells.A protective role by interleukin-17F in colon tumorigenesis.Interleukin-17 Induces Expression of Chemokines and Cytokines in Prostatic Epithelial Cells but Does Not Stimulate Cell Growth In Vitro.Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses.T helper 17 cells play a critical pathogenic role in lung cancer.Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells.Prognostic significance of interleukin 17 in cancer: a meta-analysis.Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.A cytokine-mediated link between innate immunity, inflammation, and cancer.Dendritic cell-based vaccines: barriers and opportunitiesTh17 cells in cancer: help or hindrance?Proteins and an inflammatory network expressed in colon tumors.Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.Tc17 cells in patients with uterine cervical cancerPrevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinomaIL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patientsT(H)17 cells in tumour immunity and immunotherapy.
P2860
Q21195672-21CC70F0-DC10-49D2-B9E5-001A350D455DQ24629783-D1865AD0-8021-4E55-B8AE-504D0F4ABDFAQ24646584-E7EF8818-5D56-4510-8837-AD8C2148AB1DQ24648032-58EF0F49-54B8-4CA8-96A2-AF960025D7BFQ26746887-F10FB915-A014-4A0D-A921-0016147A48D8Q26865532-0C98D710-DA4F-41C4-A4B1-C2C2B1113FAEQ27011396-CC96CCD4-3957-4F7A-A16A-184325D70E0DQ27012901-EF8E0CF4-396F-4499-B578-EFB4CA76E7F5Q28388093-24C95989-7A0B-45C7-8503-A46F0B7138DEQ28681056-4B57B69A-4A89-43B3-BB76-B0E2C9AC9856Q31081979-E9F56365-D854-4729-863E-B8B0EA530B5AQ33527427-2FB6A883-0A5F-43A8-A6A2-19D8326B41EBQ33636756-EA0381DC-746A-477E-AA85-22179A8DB349Q33698128-8B11C133-2366-402B-A2EE-723E661AA01BQ33740453-AC847954-86AF-463A-9BB3-8440DF77D1B4Q33776452-6177874E-7526-4649-B78D-CFC06D1DD5FFQ33802908-96DED009-AFB9-4BC9-998B-AEA0DC005B6EQ33869683-59278CC5-8CDE-4C40-BE11-C597341C55D5Q33951731-6EA6FA94-D46D-4AA0-9B10-BC1EC653CBF2Q33962407-D1C6B576-4600-4557-8778-20F47EB0C042Q34031403-C644C5DE-E332-404C-A77A-703AE1D6F065Q34075574-D86CCF6C-00E0-430F-BDDE-FB85A5D5C23FQ34235509-9E44BCA8-C50E-4AB3-9586-06BE355EA44DQ34269107-C7BA2595-95B4-4CDA-AB53-C7111C7761F7Q34276831-14EE68FE-AB35-4BD3-8B61-636FC6ABA827Q34413917-1F13093C-4C8E-4AD2-BD88-5E3C9F863B81Q34473935-69ADDAB4-2B34-4873-BD2E-4CE5EE461EB2Q34501647-6590AF1A-D25E-42A5-95F7-D8DF47AFF9F4Q34547722-35EB0A48-6F0B-4BE9-8D2E-C9CE33B07E3DQ34570874-531220D0-9329-43DB-A251-F33D04CAC989Q34625152-25B6505F-997B-4587-AA52-0B7E966EBB16Q34661797-6ACA94DB-0B0E-4E84-ACE0-16791116BBF5Q34913808-A51DA315-FD86-43C7-A4D3-058182C78EBAQ34958339-1E86CECE-416A-4175-B7C2-54056F10D206Q34983123-4E0B3F50-0F7F-4180-8DDD-9A5C8AC3CECFQ35093526-6A8959FE-7850-46CF-914A-63C41F104468Q35175019-ADB718AD-D47B-4205-88EC-977C30C10DEAQ35269684-F8E1974B-BDE8-4EE7-84EB-F406F2516DACQ35600093-4BD1C718-8E27-4056-8B02-5AF776ADD135Q35623903-4FAADECD-A49A-4F7B-B6AC-994A1073A771
P2860
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
@en
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
@nl
type
label
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
@en
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
@nl
prefLabel
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
@en
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.
@nl
P2093
P50
P356
P1433
P1476
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism
@en
P2093
Arnaud Ciree
Fabrice Benchetrit
François Fossiez
Guy Warnier
Nacilla Haicheur
Virginie Vives
P304
P356
10.1182/BLOOD.V99.6.2114
P407
P577
2002-03-01T00:00:00Z